Učitavanje...
Pyrazole Antagonists of the CB1 receptor with reduced brain penetration
Type 1 cannabinoid receptor (CB1) antagonists might be useful for treating obesity, liver disease, metabolic syndrome, and dyslipidemias. Unfortunately, inhibition of CB1 in the central nervous system (CNS) produces adverse effects, including depression, anxiety and suicidal ideation in some patient...
Spremljeno u:
| Izdano u: | Bioorg Med Chem |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4762035/ https://ncbi.nlm.nih.gov/pubmed/26827137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.01.033 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|